"In our pursuit of healthy, plant-based solutions for traditional medical issues, we are incorporating cannabis into our unique 280+ proprietary formulations in our efforts to become a recognized global producer of life-changing end-user products and medical raw materials (full-spectrum oil and distillates). This extends to sales and brand recognition of cannabis-based manufactured products featuring nano-technology and superior absorption and bioavailability to provide the best possible nutraceutical at the most affordable prices." https://nutranomics.com
"NutraNomics will continue its due-diligence process in preparation for a targeted acquisition closing in February. "I feel very confident that joint counsels and our independent audit will move along favorably to meet February's goal. In the meantime, our management teams will be working together to support The Plant's efforts to grow and onboard current and additional clientele," says Chairman and CEO Jonathan Bishop.